2021-2022 Adult Flu Vaccine
Award Notice Posted
- Solicitation number
- 75D301-21-D-68174
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Awarded
- to Glaxosmithkline, LLC
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75D301-21-D-10196 Federal IDV award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Durham NC 27709 USA
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice from the Department of Health and Human Services Centers for Disease Control and Prevention Office of Acquisition Services announces the award of a contract to GLAXOSMITHKLINE LLC under Request for Proposals 75D301-20-R-68174. The contract, valued at $13,040,000, is for the provision of adult flu vaccines for 2021-2022, to be delivered under indefinite delivery/indefinite quantity terms.
Notice text
Notice of Award for Request for Proposals (RFP) 75D301-20-R-68174 for Adult Flu Vaccines 2021-2022.
GLAXOSMITHKLINE LLC
5 MOORE DR RESEARCH TRIANGLE PK
DURHAM, NC 27709
Contract Number: 75D30121D10196
IDIQ Ceiling: $13,040,000.00
Awarded contract 75D301-21-D-10196 to GLAXOSMITHKLINE LLC for 13040000.00 on 2020-12-28.
Notice history
| Notice | Type | Posted |
|---|---|---|
| 2021-2022 Adult Flu Vaccine | Award Notice | |
| This notice | Award Notice | |
| 2021-2022 Adult Flu Vaccine | Award Notice | |
| 2021-2022 Adult Flu Vaccine | Award Notice | |
| 2021 Adult Flu Vaccine | Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity